Search Results 731-740 of 16339 for monoclonal antibody

  1. A Study of LY2951742 for Patients with Episodic Cluster Headaches - Mayo Clinic

    Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins; A history or presence of other medical illness that indicates ...

  2. Eye Melanoma Clinical Trials

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  3. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  4. A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation - Mayo Clinic

    A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation.

  5. Radiation Therapy Clinical Trials

    Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...

  6. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody and at least 1 steroid. Participant had at least a minimal response (MR) to the anti-CD38 antibody containing regimen and had last dose ...

  7. Research decodes one way cancer survives treatment, proposes a way to prevent it

    The team also reported that an antibody used in their research blocked the internal function of PD-L1, making the cells more sensitive to treatment. PD-L1 ...

  8. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  9. Prevalence and Predictors of Spike Protein Antibodies in COVID-19 Vaccinated Individuals - Mayo Clinic

    The objectives of this study are to determine the prevalence of spike (S) protein antibodies ... antibody development and determine how age and gender may affect ...

  10. A Study of the Effectiveness and Safety of Mepolizumab as Adjunctive Therapy in Participants with Severe Eosinophilic Asthma - Mayo Clinic

    Participants who have received any monoclonal antibody (other than Xolair) to treat inflammatory disease within 5 half-lives of visit 1; Participants who ...